Sam L. Teichman

4.8k total citations
52 papers, 2.4k citations indexed

About

Sam L. Teichman is a scholar working on Cardiology and Cardiovascular Medicine, Public Health, Environmental and Occupational Health and Surgery. According to data from OpenAlex, Sam L. Teichman has authored 52 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Cardiology and Cardiovascular Medicine, 18 papers in Public Health, Environmental and Occupational Health and 11 papers in Surgery. Recurrent topics in Sam L. Teichman's work include Pregnancy-related medical research (18 papers), Cardiac Arrest and Resuscitation (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Sam L. Teichman is often cited by papers focused on Pregnancy-related medical research (18 papers), Cardiac Arrest and Resuscitation (9 papers) and Cardiac electrophysiology and arrhythmias (8 papers). Sam L. Teichman collaborates with scholars based in United States, Italy and Netherlands. Sam L. Teichman's co-authors include Elaine Unemori, Marco Metra, John R. Teerlink, Gad Cotter, G. Michael Felker, Adriaan A. Voors, Piotr Ponikowski, Beth Davison Weatherley, Richard R. Schumacher and David A. Tate and has published in prestigious journals such as The Lancet, Journal of the American College of Cardiology and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Sam L. Teichman

51 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sam L. Teichman United States	24	1.5k	490	395	339	219	52	2.4k
Tony M. Chou United States	28	1.1k 0.8×	106 0.2×	817 2.1×	158 0.5×	374 1.7×	61	2.7k
Michael A. Brodsky United States	25	2.8k 1.9×	135 0.3×	305 0.8×	126 0.4×	181 0.8×	63	3.3k
Martin Gottwik Germany	24	1.5k 1.1×	159 0.3×	707 1.8×	176 0.5×	219 1.0×	90	2.3k
Daryl Jones Australia	21	1.3k 0.9×	134 0.3×	1.2k 3.1×	405 1.2×	586 2.7×	52	2.7k
William R. Lewis United States	29	2.0k 1.3×	75 0.2×	294 0.7×	153 0.5×	104 0.5×	87	2.5k
Maria Dorobanţu Romania	27	1.8k 1.2×	217 0.4×	521 1.3×	57 0.2×	196 0.9×	151	2.5k
R. A. Riemersma United Kingdom	19	870 0.6×	243 0.5×	533 1.3×	45 0.1×	247 1.1×	38	2.2k
Harold L. Brooks United States	27	1.2k 0.8×	60 0.1×	418 1.1×	348 1.0×	304 1.4×	74	2.2k
Davendra Mehta United States	29	2.6k 1.8×	273 0.6×	572 1.4×	147 0.4×	1.2k 5.7×	118	4.4k
Stephan A. Loer Netherlands	25	427 0.3×	129 0.3×	629 1.6×	666 2.0×	470 2.1×	152	2.2k

Countries citing papers authored by Sam L. Teichman

Since Specialization

Citations

This map shows the geographic impact of Sam L. Teichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sam L. Teichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sam L. Teichman more than expected).

Fields of papers citing papers by Sam L. Teichman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sam L. Teichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sam L. Teichman. The network helps show where Sam L. Teichman may publish in the future.

Co-authorship network of co-authors of Sam L. Teichman

This figure shows the co-authorship network connecting the top 25 collaborators of Sam L. Teichman. A scholar is included among the top collaborators of Sam L. Teichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sam L. Teichman. Sam L. Teichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shafer, Steven L., Sam L. Teichman, Neil Singla, et al.. (2024). Safety and Efficacy of Vocacapsaicin for Management of Postsurgical Pain: A Randomized Clinical Trial. Anesthesiology. 141(2). 250–261. 4 indexed citations

Odom, Guy L., Charles E. Murry, Gregory G. Mahairas, et al.. (2016). Translation of Cardiac Myosin Activation With 2-Deoxy-ATP to Treat Heart Failure Via an Experimental Ribonucleotide Reductase-Based Gene Therapy. JACC Basic to Translational Science. 1(7). 666–679. 10 indexed citations

Weiss, Gerson, Sam L. Teichman, Dennis R. Stewart, et al.. (2016). Recombinant human relaxin versus placebo for cervical ripening: a double-blind randomised trial in pregnant women scheduled for induction of labour. BMC Pregnancy and Childbirth. 16(1). 260–260. 18 indexed citations

Kadota, Shin, John A. Carey, Hans Reinecke, et al.. (2015). Ribonucleotide Reductase-Mediated Increase in dATP Improves Cardiac Performance Via Myosin Activation in a Large Animal Model of Heart Failure. European Journal of Heart Failure. 17(8). 772–781. 27 indexed citations

Voors, Adriaan A., Beth A. Davison, G. Michael Felker, et al.. (2011). Early Drop in Systolic Blood Pressure and Worsening Renal Function in Acute Heart Failure: Renal Results of Pre-RELAX-AHF. European Journal of Heart Failure. 13(9). 961–967. 90 indexed citations

Metra, Marco, John R. Teerlink, G. Michael Felker, et al.. (2010). Dyspnoea and Worsening Heart Failure in Patients with Acute Heart Failure: Results from the Pre-RELAX-AHF Study. European Journal of Heart Failure. 12(10). 1130–1139. 77 indexed citations

Cotter, Gad, Adriaan A. Voors, Beth Davison Weatherley, et al.. (2010). Acute Heart Failure Clinical Drug Development: From Planning to Proof of Activity to Phase III. Cardiology. 116(4). 292–301. 10 indexed citations

Teichman, Sam L., Elaine Unemori, John R. Teerlink, Gad Cotter, & Marco Metra. (2010). Relaxin: Review of Biology and Potential Role in Treating Heart Failure. Current Heart Failure Reports. 7(2). 75–82. 106 indexed citations

Unemori, Elaine, Baha M. Sibai, & Sam L. Teichman. (2009). Scientific Rationale and Design of a Phase I Safety Study of Relaxin in Women with Severe Preeclampsia. Annals of the New York Academy of Sciences. 1160(1). 381–384. 30 indexed citations

10.

Dschietzig, Thomas, Sam L. Teichman, Elaine Unemori, et al.. (2009). Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial. Journal of Cardiac Failure. 15(3). 182–190. 121 indexed citations

11.

Dschietzig, Thomas, Sam L. Teichman, Elaine Unemori, et al.. (2009). First Clinical Experience with Intravenous Recombinant Human Relaxin in Compensated Heart Failure. Annals of the New York Academy of Sciences. 1160(1). 387–392. 15 indexed citations

12.

Silberbauer, John, et al.. (2008). A preliminary assessment of the effects of ATI-2042 in subjects with paroxysmal atrial fibrillation using implanted pacemaker methodology. EP Europace. 11(4). 458–464. 26 indexed citations

13.

Wallace, Mark S., Dwight E. Moulin, Ronald A. Wasserman, et al.. (2006). A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008—a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia. Journal of Opioid Management. 2(3). 167–173. 20 indexed citations

14.

Froestl, Wolfgang, Michela Gallagher, Helen Jenkins, et al.. (2004). SGS742: the first GABAB receptor antagonist in clinical trials. Biochemical Pharmacology. 68(8). 1479–1487. 145 indexed citations

15.

Carney, Robert J., et al.. (1992). Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. Journal of the American College of Cardiology. 20(1). 17–23. 62 indexed citations

16.

Aufderheide, Tom P., Michael H. Keelan, Gail E Hendley, et al.. (1992). Milwaukee prehospital chest pain project — Phase I: Feasibility and accuracy of prehospital thrombolytic candidate selection. The American Journal of Cardiology. 69(12). 991–996. 65 indexed citations

17.

Teichman, Sam L., et al.. (1991). Utility of serial creatine kinase MB levels during initial assessment of acute chest pain. Journal of the American College of Cardiology. 17(2). A330–A330. 3 indexed citations

18.

Kereiakes, Dean J., W.Douglas Weaver, Jeffrey L. Anderson, et al.. (1990). Time delays in the diagnosis and treatment of acute myocardial infarction: A tale of eight cities Report from the Pre-hospital Study Group and the Cincinnati Heart Project. American Heart Journal. 120(4). 773–780. 149 indexed citations

19.

Karagounis, Labros A., et al.. (1990). Impact of field-transmitted electrocardiography on time to in-hospital thrombolytic therapy in acute myocardial infarction. The American Journal of Cardiology. 66(10). 786–791. 129 indexed citations

20.

Teichman, Sam L., Aileen M. Ferrick, Soo G. Kim, et al.. (1987). Disopyramide-pyridostigmine interaction: Selective reversal of anticholinergic symptoms with preservation of antiarrhythmic effect. Journal of the American College of Cardiology. 10(3). 633–641. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact